In this study, although the patient number of administered G-CSF in the re-administration group was limited; therefore, caution is required when interpreting the findings in G-CSF administration group, but the incidence of leukopenia and G-CSF administration was similar between the first administration and re-administration of ATD. The gene discussed is CSF3; the disease is Decreased total leukocyte count.